Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness: A Randomized Controlled Study

NCT03566069 is registered in ClinicalTrials.gov with Shalvata Mental Health Center as lead sponsor.

NCT NCT03566069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03566069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness: A Randomized Controlled Study
Lead sponsor
Shalvata Mental Health Center
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2018
Completion date
June 30, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe mental illness